Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
38.15
-0.47 (-1.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 594 employees as of December 31, 2025. The number of employees increased by 157 or 35.93% compared to the previous year.
Employees
594
Change (1Y)
157
Growth (1Y)
35.93%
Revenue / Employee
$12,956
Profits / Employee
-$783,362
Market Cap
3.99B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Amicus Therapeutics | 511 |
| Travere Therapeutics | 497 |
| Catalyst Pharmaceuticals | 182 |
| Tango Therapeutics | 137 |
| NewAmsterdam Pharma Company | 100 |
CRNX News
- 1 day ago - Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults - GlobeNewsWire
- 20 days ago - Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly - GlobeNewsWire
- 7 weeks ago - Crinetics Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Crinetics Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March - GlobeNewsWire
- 3 months ago - Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire